Asia Pacific Multi Cancer Early Detection Market Size & Outlook
- Clinical Diagnostics
- Cancer Diagnostics
- Multi Cancer Early Detection Market Outlook
- Cancer Diagnostics
Global Market
Related Markets
Ask Prism AI anything about the multi cancer early detection market
Get a cited answer from GVR research in seconds: segment shares, growth drivers, regulation and forecast assumptions.
Asia Pacific multi cancer early detection market highlights
- The Asia Pacific multi cancer early detection market generated a revenue of USD 249.6 million in 2024.
- The market is expected to grow at a CAGR of 17.8% from 2025 to 2030.
- In terms of segment, gene panel, ldt & others was the largest revenue generating type in 2024.
- Liquid Biopsy is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, China is expected to register the highest CAGR from 2025 to 2030.
Asia Pacific data book summary
| Market revenue in 2024 | USD 249.6 million |
| Market revenue in 2030 | USD 663.9 million |
| Growth rate | 17.8% (CAGR from 2025 to 2030) |
| Largest segment | Gene panel, ldt & others |
| Fastest growing segment | Liquid Biopsy |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Liquid Biopsy, Gene Panel, LDT & Others |
| Key market players worldwide | Illumina Inc, Exact Sciences Corp, Foundation Medicine, Guardant Health Inc, Burning Rock Biotech Ltd ADR, Freenome, AnchorDx, GeneCast, Elypta |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 22.4% of the global multi cancer early detection market in 2024.
- Globally, Europe is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 663.9 million by 2030.
Asia Pacific MCED market is expected to grow at a lucrative rate owing to various factors, such as increasing healthcare reforms. Other factors contributing to market growth are improving healthcare infrastructure, a growing population, and rising number of local companies entering the market. Asia Pacific has a large population and high prevalence of cancer.
Thus, usage of screening tests for cancer has increased in the past few years owing to growing government initiatives, such as free screening for cervical cancer, breast cancer, & lung cancer, as well as increasing collaborations between governments, research institutes, & companies for distribution & supply of these tests.
In Asia Pacific, cancer has drawn more attention as a result of demographic shifts brought on by urbanization, aging populations, and economic expansion. High prevalence of health risk factors, such as increasing alcohol & cigarette consumption, poor diets, and sedentary lifestyle, are contributing to the increasing prevalence of cancers.
No credit card required*
Publish Date: Feb 19, 2025
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
- Turnaround
- 5–10 working days
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Multi Cancer Early Detection Market Scope
Multi Cancer Early Detection Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Illumina Inc | View profile | 9,300 | 5200 Illumina Way, San Diego, CA, United States, 92122 | www.illumina.com |
| Guardant Health Inc | View profile | 1,779 | 3100 Hanover Street, Palo Alto, CA, United States, 94304 | www.guardanthealth.com |
| Exact Sciences Corp | View profile | 6,600 | 5505 Endeavor Lane, Madison, WI, United States, 53719 | www.exactsciences.com |
| Freenome | View profile | 501-1000 | South San Francisco, California, United States, North America | www.freenome.com |
| Foundation Medicine | View profile | 251-500 | Cambridge, Massachusetts, United States, North America | www.foundationmedicine.com |
| Burning Rock Biotech Ltd ADR | View profile | 786 | No. 5, Xingdao Ring Road North, International Bio Island, Guangzhou, China, People's Republic of, 510005 | www.brbiotech.com |
| AnchorDx | View profile | 51-100 | Guangzhou, Guangdong, China, Asia | www.anchordx.com/ |
| GeneCast | View profile | 1-10 | Seoul, Seoul-t'ukpyolsi, South Korea, Asia | genecast.co.kr |
| Elypta | View profile | 11-50 | Stockholm, Stockholms Lan, Sweden, Europe | www.elypta.com/ |
Asia Pacific Multi Cancer Early Detection Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Multi Cancer Early Detection Market Outlook will help companies and investors design strategic landscapes.
Gene Panel, Ldt & Others was the largest segment with a revenue share of 106.81% in 2024.
Horizon Databook has segmented the Asia Pacific multi cancer early detection market based on liquid biopsy, gene panel, ldt & others covering the revenue growth of each sub-segment from 2018 to 2030.
Asia Pacific MCED market is expected to grow at a lucrative rate owing to various factors, such as increasing healthcare reforms. Other factors contributing to market growth are improving healthcare infrastructure, a growing population, and rising number of local companies entering the market. Asia Pacific has a large population and high prevalence of cancer.
Thus, usage of screening tests for cancer has increased in the past few years owing to growing government initiatives, such as free screening for cervical cancer, breast cancer, & lung cancer, as well as increasing collaborations between governments, research institutes, & companies for distribution & supply of these tests.
In Asia Pacific, cancer has drawn more attention as a result of demographic shifts brought on by urbanization, aging populations, and economic expansion. High prevalence of health risk factors, such as increasing alcohol & cigarette consumption, poor diets, and sedentary lifestyle, are contributing to the increasing prevalence of cancers.
- Asia Pacific Multi Cancer Early Detection Market Type Outlook (Revenue, USD Million , 2018-2030)
- Liquid Biopsy
- Gene Panel, LDT & Others
- Asia Pacific Multi Cancer Early Detection Market End Use Outlook (Revenue, USD Million , 2018-2030)
- Hospitals
- Diagnostic Laboratories
- Others
Reasons to subscribe to Multi Cancer Early Detection Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Multi Cancer Early Detection Market Outlook databook
- Our clientele includes a mix of Multi Cancer Early Detection Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific Multi Cancer Early Detection Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific Multi Cancer Early Detection Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Asia Pacific Multi Cancer Early Detection Market, 2018-2030 (US$M)
Asia Pacific multi cancer early detection market statistics, by type, 2018-2030 (US$M)
